Literature DB >> 21911786

Acute hypoglycemia decreases myocardial blood flow reserve in patients with type 1 diabetes mellitus and in healthy humans.

Omar Rana1, Christopher D Byrne, David Kerr, David V Coppini, Soha Zouwail, Roxy Senior, Joe Begley, Jeremy J Walker, Kim Greaves.   

Abstract

BACKGROUND: Hypoglycemia is associated with increased cardiovascular mortality, but the reason for this association is poorly understood. We tested the hypothesis that the myocardial blood flow reserve (MBFR) is decreased during hypoglycemia using myocardial contrast echocardiography in patients with type 1 diabetes mellitus (DM) and in healthy control subjects. METHODS AND
RESULTS: Twenty-eight volunteers with DM and 19 control subjects underwent hyperinsulinemic clamps with maintained sequential hyperinsulinemic euglycemia (plasma glucose, 90 mg/dL [5.0 mmol/L]) followed by hyperinsulinemic hypoglycemia (plasma glucose, 50 mg/dL [2.8 mmol/L]) for 60 minutes each. Low-power real-time myocardial contrast echocardiography was performed with flash impulse imaging using low-dose dipyridamole stress at baseline and during hyperinsulinemic euglycemia and hyperinsulinemic hypoglycemia. In control subjects, MBFR increased during hyperinsulinemic euglycemia by 0.57 U (22%) above baseline (B coefficient, 0.57; 95% confidence interval, 0.38 to 0.75; P<0.0001) and decreased during hyperinsulinemic hypoglycemia by 0.36 U (14%) below baseline values (B coefficient, -0.36; 95% confidence interval, -0.50 to -0.23; P<0.0001). Although MBFR was lower in patients with DM at baseline by 0.37 U (14%; B coefficient, -0.37; 95% confidence interval, -0.55 to -0.19; P=0.0002) compared with control subjects at baseline, the subsequent changes in MBFR during hyperinsulinemic euglycemia and hyperinsulinemic hypoglycemia in DM patients were similar to that observed in control subjects. Finally, the presence of microvascular complications in the patients with DM was associated with a reduction in MBFR of 0.52 U (24%; B coefficient, -0.52; 95% confidence interval, -0.70 to -0.34; P<0.0001).
CONCLUSIONS: Hypoglycemia decreases MBFR in both healthy humans and patients with DM. This finding may explain the association between hypoglycemia and increased cardiovascular mortality in susceptible individuals.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21911786     DOI: 10.1161/CIRCULATIONAHA.110.992297

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  20 in total

1.  [Therapeutic targets in arterial hypertension and diabetes mellitus. Can medical prevention be harmful?].

Authors:  C Chatzikyrkou; H Haller; J Menne
Journal:  Internist (Berl)       Date:  2012-07       Impact factor: 0.743

2.  A Comprehensive Performance Evaluation of Five Blood Glucose Systems in the Hypo-, Eu-, and Hyperglycemic Range.

Authors:  Eric Zijlstra; Lutz Heinemann; Annelie Fischer; Christoph Kapitza
Journal:  J Diabetes Sci Technol       Date:  2016-11-01

3.  Rate-of-Change Dependence of the Performance of Two CGM Systems During Induced Glucose Swings.

Authors:  Stefan Pleus; Michael Schoemaker; Karin Morgenstern; Günther Schmelzeisen-Redeker; Cornelia Haug; Manuela Link; Eva Zschornack; Guido Freckmann
Journal:  J Diabetes Sci Technol       Date:  2015-04-07

Review 4.  Echocardiographic feature of diabetic cardiomyopathy: where are we now?

Authors:  Kazuaki Negishi
Journal:  Cardiovasc Diagn Ther       Date:  2018-02

5.  Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC.

Authors:  Venkatesh L Murthy; Timothy M Bateman; Rob S Beanlands; Daniel S Berman; Salvador Borges-Neto; Panithaya Chareonthaitawee; Manuel D Cerqueira; Robert A deKemp; E Gordon DePuey; Vasken Dilsizian; Sharmila Dorbala; Edward P Ficaro; Ernest V Garcia; Henry Gewirtz; Gary V Heller; Howard C Lewin; Saurabh Malhotra; April Mann; Terrence D Ruddy; Thomas H Schindler; Ronald G Schwartz; Piotr J Slomka; Prem Soman; Marcelo F Di Carli; Andrew Einstein; Raymond Russell; James R Corbett
Journal:  J Nucl Cardiol       Date:  2018-02       Impact factor: 5.952

Review 6.  Neuroendocrine System Regulatory Mechanisms: Acute Coronary Syndrome and Stress Hyperglycaemia.

Authors:  Ricardo A Perez de la Hoz; Sandra Patricia Swieszkowski; Federico Matias Cintora; Jose Martin Aladio; Claudia Mariana Papini; Maia Matsudo; Alejandra Silvia Scazziota
Journal:  Eur Cardiol       Date:  2018-08

7.  Effects of equivalent sympathetic activation during hypoglycemia on endothelial function and pro-atherothrombotic balance in healthy individuals and obese standard treated type 2 diabetes.

Authors:  Nino G Joy; Maia Mikeladze; Lisa M Younk; Donna B Tate; Stephen N Davis
Journal:  Metabolism       Date:  2016-09-12       Impact factor: 8.694

Review 8.  Coronary artery disease and diabetes mellitus.

Authors:  Doron Aronson; Elazer R Edelman
Journal:  Cardiol Clin       Date:  2014-06-10       Impact factor: 2.213

9.  Comparative effects of acute hypoglycemia and hyperglycemia on pro-atherothrombotic biomarkers and endothelial function in non-diabetic humans.

Authors:  Nino G Joy; Jennifer M Perkins; Maia Mikeladze; Lisa Younk; Donna B Tate; Stephen N Davis
Journal:  J Diabetes Complications       Date:  2016-07-04       Impact factor: 2.852

Review 10.  Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications.

Authors:  Brian M Frier
Journal:  Nat Rev Endocrinol       Date:  2014-10-07       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.